Megumi Funakoshi‐Tago

2.9k total citations
101 papers, 2.3k citations indexed

About

Megumi Funakoshi‐Tago is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Megumi Funakoshi‐Tago has authored 101 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 28 papers in Oncology and 22 papers in Immunology. Recurrent topics in Megumi Funakoshi‐Tago's work include Cytokine Signaling Pathways and Interactions (24 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers) and NF-κB Signaling Pathways (13 papers). Megumi Funakoshi‐Tago is often cited by papers focused on Cytokine Signaling Pathways and Interactions (24 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers) and NF-κB Signaling Pathways (13 papers). Megumi Funakoshi‐Tago collaborates with scholars based in Japan, United States and France. Megumi Funakoshi‐Tago's co-authors include Kenji Tago, Tadashi Kasahara, Yoshiko Sonoda, Tadahiko Mashino, Hiroomi Tamura, Shigeo Nakamura, Shin‐ichi Tominaga, James N. Ihle, Hideo Inoue and S. William Pelletier and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and The Journal of Immunology.

In The Last Decade

Megumi Funakoshi‐Tago

94 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Megumi Funakoshi‐Tago Japan 28 1.0k 490 398 324 240 101 2.3k
Ming‐Jen Hsu Taiwan 31 1.1k 1.1× 395 0.8× 347 0.9× 135 0.4× 77 0.3× 70 2.3k
Yumiko Yasui Japan 30 1.1k 1.0× 211 0.4× 283 0.7× 238 0.7× 72 0.3× 74 2.5k
Eun‐Yi Moon South Korea 32 1.4k 1.4× 659 1.3× 329 0.8× 130 0.4× 88 0.4× 108 2.8k
Tai‐Ping Fan United Kingdom 29 1.8k 1.7× 193 0.4× 424 1.1× 368 1.1× 100 0.4× 76 2.8k
Xuechun Li China 18 893 0.9× 262 0.5× 329 0.8× 298 0.9× 129 0.5× 48 2.0k
Yuling Qiu China 26 1.3k 1.2× 165 0.3× 297 0.7× 190 0.6× 113 0.5× 89 2.4k
Duncan H. Mak United States 33 1.6k 1.6× 262 0.5× 428 1.1× 153 0.5× 280 1.2× 88 2.5k
Shireen Vali United States 23 1.2k 1.1× 178 0.4× 497 1.2× 153 0.5× 82 0.3× 67 2.1k
Min Young Lee South Korea 30 1.6k 1.6× 346 0.7× 293 0.7× 142 0.4× 150 0.6× 110 2.6k
Jun Sun United States 35 2.1k 2.0× 634 1.3× 915 2.3× 118 0.4× 123 0.5× 80 5.1k

Countries citing papers authored by Megumi Funakoshi‐Tago

Since Specialization
Citations

This map shows the geographic impact of Megumi Funakoshi‐Tago's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megumi Funakoshi‐Tago with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megumi Funakoshi‐Tago more than expected).

Fields of papers citing papers by Megumi Funakoshi‐Tago

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megumi Funakoshi‐Tago. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megumi Funakoshi‐Tago. The network helps show where Megumi Funakoshi‐Tago may publish in the future.

Co-authorship network of co-authors of Megumi Funakoshi‐Tago

This figure shows the co-authorship network connecting the top 25 collaborators of Megumi Funakoshi‐Tago. A scholar is included among the top collaborators of Megumi Funakoshi‐Tago based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megumi Funakoshi‐Tago. Megumi Funakoshi‐Tago is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tago, Kenji, Yasuhiro Moriwaki, Hidemi Misawa, et al.. (2023). Suppression of Neuroinflammation by Coffee Component Pyrocatechol via Inhibition of NF-κB in Microglia. International Journal of Molecular Sciences. 25(1). 316–316. 8 indexed citations
2.
Tago, Kenji, et al.. (2023). The acetylation of STAT3 at K685 attenuates NPM-ALK-induced tumorigenesis. Cellular Signalling. 114. 110985–110985. 6 indexed citations
3.
Funakoshi‐Tago, Megumi, et al.. (2022). Identification of DDX5 as an indispensable activator of the glucocorticoid receptor in adipocyte differentiation. FEBS Journal. 290(4). 988–1007. 4 indexed citations
4.
Funakoshi‐Tago, Megumi, et al.. (2020). Coffee decoction enhances tamoxifen proapoptotic activity on MCF-7 cells. Scientific Reports. 10(1). 19588–19588. 11 indexed citations
5.
Nakazawa, Yosuke, Naoki Morishita, Shin Endo, et al.. (2020). Oral consumption of α-glucosyl-hesperidin could prevent lens hardening, which causes presbyopia. Biochemistry and Biophysics Reports. 25. 100885–100885. 10 indexed citations
6.
Funakoshi‐Tago, Megumi, et al.. (2020). Pyrocatechol, a component of coffee, suppresses LPS-induced inflammatory responses by inhibiting NF-κB and activating Nrf2. Scientific Reports. 10(1). 2584–2584. 42 indexed citations
7.
Tago, Kenji, Megumi Funakoshi‐Tago, Satoshi Ohta, et al.. (2019). Oncogenic Ras mutant causes the hyperactivation of NF‐κB via acceleration of its transcriptional activation. Molecular Oncology. 13(11). 2493–2510. 14 indexed citations
8.
Tago, Kenji, Satoshi Ohta, Masaki Kashiwada, et al.. (2017). ST2 gene products critically contribute to cellular transformation caused by an oncogenic Ras mutant. Heliyon. 3(10). e00436–e00436. 8 indexed citations
9.
Funakoshi‐Tago, Megumi, et al.. (2017). Coffee extract inhibits adipogenesis in 3T3-L1 preadipocyes by interrupting insulin signaling through the downregulation of IRS1. PLoS ONE. 12(3). e0173264–e0173264. 50 indexed citations
10.
Tago, Kenji, Yosuke Nakazawa, Tomoyuki Ohe, et al.. (2017). Alpha-tocopherol attenuates the anti-tumor activity of crizotinib against cells transformed by NPM-ALK. PLoS ONE. 12(8). e0183003–e0183003. 12 indexed citations
11.
Miyamoto, Yuki, Tomohiro Torii, Akito Tanoue, et al.. (2017). Data on the effect of hypomyelinating leukodystrophy 6 (HLD6)-associated mutations on the TUBB4A properties. Data in Brief. 11. 284–289. 3 indexed citations
12.
Funakoshi‐Tago, Megumi, et al.. (2016). Phosphorylated CIS suppresses the Epo or JAK2 V617F mutant-triggered cell proliferation through binding to EpoR. Cellular Signalling. 31. 41–57. 10 indexed citations
13.
Tago, Kenji, et al.. (2016). Three Tyrosine Residues in the Erythropoietin Receptor Are Essential for Janus Kinase 2 V617F Mutant-induced Tumorigenesis. Journal of Biological Chemistry. 292(5). 1826–1846. 10 indexed citations
14.
Funakoshi‐Tago, Megumi, Toshiro Watanabe, Kenji Tago, et al.. (2014). Effect of chemical modification on the ability of pyrrolidinium fullerene to induce apoptosis of cells transformed by JAK2 V617F mutant. International Immunopharmacology. 20(1). 258–263. 10 indexed citations
15.
16.
Funakoshi‐Tago, Megumi, et al.. (2009). The polycythemia vera-associated Jak2 V617F mutant induces tumorigenesis in nude mice. International Immunopharmacology. 9(7-8). 870–877. 20 indexed citations
17.
Funakoshi‐Tago, Megumi, Kenji Tago, Tadashi Kasahara, Evan Parganas, & James N. Ihle. (2008). Negative regulation of Jak2 by its auto-phosphorylation at tyrosine 913 via the Epo signaling pathway. Cellular Signalling. 20(11). 1995–2001. 19 indexed citations
18.
Funakoshi‐Tago, Megumi, S. William Pelletier, Hiroshi Moritake, Evan Parganas, & James N. Ihle. (2007). Jak2 FERM Domain Interaction with the Erythropoietin Receptor Regulates Jak2 Kinase Activity. Molecular and Cellular Biology. 28(5). 1792–1801. 66 indexed citations
19.
Funakoshi‐Tago, Megumi, S. William Pelletier, Tadashi Matsuda, Evan Parganas, & James N. Ihle. (2006). Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2. The EMBO Journal. 25(20). 4763–4772. 55 indexed citations
20.
Ichikawa, Daiju, Megumi Funakoshi‐Tago, Eriko Aizu-Yokota, et al.. (2006). TNF-receptor associated factor 6-deficient fibroblast is sensitive to the TNF-α-induced cell death: Involvement of reactive oxygen species. Biochemical and Biophysical Research Communications. 351(1). 93–98. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ming‐Jen Hsu Breakdown of academic impact, for papers by Yumiko Yasui Breakdown of academic impact, for papers by Eun‐Yi Moon Breakdown of academic impact, for papers by Tai‐Ping Fan Breakdown of academic impact, for papers by Xuechun Li Breakdown of academic impact, for papers by Yuling Qiu Breakdown of academic impact, for papers by Duncan H. Mak Breakdown of academic impact, for papers by Shireen Vali Breakdown of academic impact, for papers by Min Young Lee Breakdown of academic impact, for papers by Jun Sun
Rankless by CCL
2026